Krystal Bergin
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- Peptidase Inhibition and Analysis
Papers in
- Hematology 27
- Multiple Myeloma Research and Treatments 26
- Hematopoietic Stem Cell Transplantation 4
-
- Protein Degradation and Inhibitors 13
- Cancer therapeutics and mechanisms 3
- Histone Deacetylase Inhibitors Research 2
- Co-authors
- Andrew Spencer (27 shared papers)Elizabeth Moore (7 shared papers)Erica M. Wood (7 shared papers)Zoe McQuilten (7 shared papers)Anna Kalff (14 shared papers)Simon J. Harrison (6 shared papers)Paul Cameron (2 shared papers)Michelle K. Yong (2 shared papers)
- Journals
- Blood (6 papers)British Journal of Haematology (4 papers)Bone Marrow Transplantation (3 papers)Frontiers in Oncology (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- AustraliaNew ZealandUnited States
In The Last Decade
Krystal Bergin
28 papers receiving 344 citations
Peers
Comparison fields: 5 of 54
- Hematology 222
- Oncology 125
- Genetics 41
- Cancer Research 44
- Molecular Biology 176
Countries citing papers authored by Krystal Bergin
This map shows the geographic impact of Krystal Bergin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krystal Bergin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krystal Bergin more than expected).
Fields of papers citing papers by Krystal Bergin
This network shows the impact of papers produced by Krystal Bergin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krystal Bergin. The network helps show where Krystal Bergin may publish in the future.
Co-authors
The 25 scholars most cited alongside Krystal Bergin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 60 | |
| 2 | 2017 | 59 | |
| 3 | 2019 | 46 | |
| 4 | 2016 | 27 | |
| 5 | 2016 | 22 | |
| 6 | 2019 | 17 | |
| 7 | 2017 | 15 | |
| 8 | 2022 | 13 | |
| 9 | 2018 | 12 | |
| 10 | 2018 | 11 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 9 | |
| 13 | 2019 | 9 | |
| 14 | 2016 | 7 | |
| 15 | 2021 | 6 | |
| 16 | 2017 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2016 | 3 | |
| 19 | 2020 | 3 | |
| 20 | 2019 | 2 |
About Krystal Bergin
Krystal Bergin is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Immunology, having authored 29 papers that have together received 348 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (13 papers), Peptidase Inhibition and Analysis (8 papers), Cancer Treatment and Pharmacology (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Cancer therapeutics and mechanisms (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Hematology (222 citations), Oncology (125 citations), Genetics (41 citations), Cancer Research (44 citations) and Molecular Biology (176 citations). Krystal Bergin has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include Andrew Spencer, Elizabeth Moore, Erica M. Wood, Zoe McQuilten, Anna Kalff, Simon J. Harrison, Paul Cameron, Michelle K. Yong, Sharon R. Lewin and Patricia Walker. Their work appears in journals such as Blood, British Journal of Haematology, Bone Marrow Transplantation, Frontiers in Oncology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.